Buying Medicines Online - NPA Advice The NPA shares concerns of GPs that patients are suffering adverse reactions caused by medicines bought over the internet. (GP magazine, 17 April 2009) and would advise members of the public to be aware of the risks and talk to their local pharmacist if they have concerns. People do need to be aware that medicines purchased over the internet may not be to the same standard as those obtained from a UK
pharmacy.
Source: www.medicalnewstoday.comLumbar Fusion Has Long-Term Benefits Lumbar fusion is becoming an increasingly common treatment for low-back pain, but its long-term effects are relatively unknown. A doctoral thesis from the Swedish medical university Karolinska Institutet now shows that the long-term effects are superior to those of physiotherapy. Chronic low-back pain is treated increasingly often with lumbar fusion, by which several lower back vertebrae are fused in a way that has little impact on the back's overall mobility.
Source: www.medicalnewstoday.comLabopharm Reports Results For Phase III Study On Twice-daily Tramadol-acetaminophen Formulation Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) announced the results of its recently completed North American Phase III clinical trial for its twice-daily formulation of tramadol and acetaminophen (study 06CCL3-001). Study 06CCL3-001 was a multi-centre, randomized, double-blind, parallel-arm study that compared the efficacy and safety of Labopharm's twice-daily tramadol-acetaminophen formulation to placebo in the treatment of moderate to severe acute low back pain.
Source: www.medicalnewstoday.comPersistent Low-Back Pain Reduced By Motor Control Exercises Motor control exercises, when performed in conjunction with other forms of therapy, can significantly reduce pain and disability in patients with persistent low back pain, according to a new systematic review published in the January issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
Source: www.medicalnewstoday.comPsylin Neurosciences Commences Development Of Compound For Depression Psylin Neurosciences Inc., a joint venture biotechnology company spun out of Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. announced that it has initiated IND-enabling development of a novel compound, PSN0041, for the treatment of depression. PSN0041, a peptide from Amylin's proprietary polypeptide hormone library, PHORMOL, was identified as having utility in depression after screening it in PsychoGenics' proprietary, drug discovery technologies.
Source: www.medicalnewstoday.comURAC Director Of Pharmacy Programs To Speak At Academy Of Managed Care Pharmacy Annual Meeting URAC, the leading health care accreditation and education organization, announced that Director of
Pharmacy Programs Janice Anderson, RPh, has been selected to speak at the 21st Annual Academy of Managed Care
Pharmacy (AMCP) Meeting, the largest assembly of
pharmacy and health care professionals dedicated solely to the issues of managed care
pharmacy. Ms.
Source: www.medicalnewstoday.comA Synthetic Peptide That Enhances Bone Growth Patented By Brookhaven Lab And BioSET, Inc., Brookhaven Science Associates, the company that operates and manages the U.S. Department of Energy's Brookhaven National Laboratory (BNL), and Biosurface Engineering Technologies, Inc. (BioSET), have been issued a U.S. patent on a synthetic peptide, called B2A. "About 250,000 Americans undergo lumbar spine fusion surgeries each year to treat lower back pain," said Tom Rouche, BioSET President and CEO.
Source: www.medicalnewstoday.comDrugmakers Reduce Spending On Prescription Drug Advertising Drugmakers in 2008 reduced their spending on consumer advertising of
prescription drugs by 8% to $4.4 billion, the first cutback since at least the late 1990s, the Wall Street Journal reports. Print advertising for pharmaceuticals declined by 18%, while television advertising declined by 4%, according to IMS Health.
Prescription drug advertisements "have surged" since 1997 when
Source: www.medicalnewstoday.comEasing Back Pain Through Weights, Not Aerobics People who use weight training to ease their lower back pain are better off than those who choose other forms of exercise such as jogging, according to a University of Alberta study. The study, done in conjunction with the University of Regina, showed a 60 per cent improvement in pain and function levels for people with chronic backache who took part in a 16-week exercise program of resistance training using dumbbells, barbells and other load-bearing exercise equipment.
Source: www.medicalnewstoday.comFDA Adopts Interim Plan To Avoid Shortage Of Medically Necessary Opioid The U.S Food and Drug Administration amended its March 30, 2009, action warning manufacturers to stop the production and distribution of certain unapproved
prescription opioids, to allow the continued marketing and distribution of one particular type of opioid -- a high concentrate morphine sulfate oral solution -- on an interim basis.
Source: www.medicalnewstoday.com
# posted by Network @ 10:20 AM
